Home  »  Ipo Review  »  Sotac Pharmaceuticals Ipo

Let’s have a detailed review of the company and analytics of the Sotac Pharmaceuticals IPO release date, IPO offer price, subscription, Sotac Pharmaceuticals Limited IPO allotment, grey market price, and other details like the company’s background, its financial positions, its promoters, and other related things.

Face Value Rs 10
Price Band Rs 105 to Rs 111
Listing At NSE, SME
Min. Order Quantity 1200 Shares
Listing Date Apr 13, 2023
Offer for Sale Rs Lakh
Fresh Issue Rs 3,330 Lakh
IPO Size Rs 3,330 Lakh
Tick Size 1

Sotac Pharmaceuticals IPO is listed at a [●] premium. Check out the live share price by clicking on the below link.

Live Performance – Sotac Pharmaceuticals Share Price

Sotac Pharmaceuticals IPO – Summary

Sotac Pharmaceuticals IPOTheir Company was originally formed and registered as a Partnership Firm under the Partnership Act, 1932 (“Partnership Act”) in the name and style of “M/s Sotac Pharmaceuticals”, pursuant to a deed of partnership dated October 28, 2015.

Thereafter “M/s. Sotac Pharmaceuticals” was converted from Partnership Firm to a Private Limited Company under Part I (Chapter XXI) of the Companies Act, 2013 in the name of “Sotac Pharmaceuticals Private Limited” and received a certificate of incorporation dated December 18, 2015, from the Assistant Registrar of Companies, Gujarat.


Sotac Pharmaceuticals IPO Date

The opening and closing dates of Sotac Pharmaceuticals IPO are Mar 29, 2023, and Apr 3, 2023, respectively.

Sotac Pharmaceuticals IPO Subscription

Day / Date NII RII Total Subscription
1st Day – 29th Mar 0.00x 0.05x 0.02x
2nd Day –  31st Mar 0.72x 0.15x 0.23x
3rd Day – 3rd Apr 4.04x 0.91x 1.60x
Shares Offered or Net Issue 428,400 998,400 2,850,000

The shares subscribed by the public will be updated here.

Sotac Pharmaceuticals IPO Allotment Status

Here, you can find the Allotment Status of this IPO.

Allotment of Equity Shares pursuant to the Fresh Issue and transfer of the Offered Shares of the Promoter Selling Shareholders pursuant to the Offer for Sale to the successful Bidders. However, the Allotment Status is not yet disclosed.

Sotac Pharmaceuticals Limited IPO Listing Date

Find the dates below on the basis of allotment, refund, listing, and more:

Basis of Allotment Finalization Apr 10, 2023
Refunds Initiation Apr 11, 2023
Credit of Shares to Demat Account Apr 12, 2023
Share Listing Date Apr 13, 2023

Sotac Pharmaceuticals IPO Price Band

The face value of each share is Rs.10, but the price band of the IPO is Rs 105 to Rs 111 

Sotac Pharmaceuticals IPO Equity Size

This Initial Public Issue of 3,000,000 Equity Shares of Rs.10 each for cash at a price of Rs 105 to Rs 111 per equity share aggregating to Rs.3,330 Lakh.

Sotac Pharmaceuticals IPO Share Offering

Fresh Issue: The Issue (excluding the Market Maker Reservation Portion) of 3,000,000 Equity Shares of Rs.10/ each.

Issue Size: 3,000,000 Equity Shares of Rs.10 each, aggregating to Rs.3,330 Lakh

Open Free Demat Account Now!

    Fill Your Details Here
    1. Open Demat AccountInvest in IPO

    Sotac Pharmaceuticals IPO – Live Performance

    The listing date of this IPO is Apr 13, 2023. You can check the live performance of the IPO here, only after it is listed on exchanges.

    Live IPO Performance – Sotac Pharmaceuticals Share Price

    Sotac Pharmaceuticals IPO Grey Market Premium

    The Sotac Pharmaceuticals Limited IPO Grey Market Premium price is Rs X, the Kostak rate is Rs X and the Subject to Sauda is Rs X. 

    Sotac Pharmaceuticals IPO – Company Overview

    SOTAC Pharmaceuticals Limited is part of the SOTAC group, based in Gujarat. Their company has been founded by their visionary promoters Mr Sharadkumar Dashrathbhai Patel, Mr Dineshkumar Babulal Gelot, Mr Vishalkumar Devrajbhai Patel, Mr Chetankumar Bachubhai Patel and Late Mr Baldevbhai Trikambhai Jotania.

    One of their current promoters Mrs. Kiranben Baldevbhai Jotania, wife of the Late Mr Baldevbhai Trikambhai Jotania, acquired 4,09,000 shares by way of transmission of shares due to his death.

    They are in the business of manufacturing pharmaceutical products for different marketers on a loan license or contract manufacturing basis. Their business is majorly on principle to principle basis with different marketers.

    As of the date of this Red Herring Prospectus, they cater to 162 corporate clients on a loan licence and/or contract manufacturing basis. Their company commenced manufacturing facility in the year 2017, hence, their company has experience of more than 5 years in the current line of business of their company.

    Sotac Pharmaceuticals IPO – Financial Statements

    A quick look into the past financial performance of the company to understand its performance of the business and evaluate the growth prospectus:

    Financial Summary:

    Amount (in INR & Lakh)
    30-Sep-22 31-Mar-22 Mar-21 31-Mar-20
    Total Assets 6,461.60 3,525.35 3,469.75 3,038.21
    *Total Revenue 3,994.65 7,337.02 4,894.97 2,882.64
    Total Expense 3,824.55 6,867.55 5,100.62 2,846.94
    Profit After Tax 46.55 287.86 (236.54) 8.75

    Earnings per Equity Share (in Lakh)

    30-Sep-22 31-Mar-22 Mar-21 31-Mar-20
    Basic  2.02 12.51 (10.28) 0.89
    Diluted 0.58 3.58 (2.94) 0.13

    Further, their PAT for the period ended on Sep 30, 2022, March 31, 2022, March 31, 2021, and March 31, 2020, were Rs. 46.55 Lakh, Rs. 287.86 Lakh, Rs. (236.54) Lakh and Rs. 8.75 Lakh respectively.

    Sotac Pharmaceuticals IPO – Promoters

    The Promoter of this company is:


    List of Related Parties (Key Managerial Personnel)

    • Sharadkumar Dashrathbhai Patel – Chairman and Managing Director
    • Dineshkumar Babulal Gelot – Whole Time Director
    • Chetankumar Bachubhai Patel – Executive Director
    • Vishalkumar Devrajbhai Patel – Executive Director
    • Nidhiben Patel – Independent Director
    • Hetal Umangbhai Shah – Independent Director
    • Heena Viral Patel – Independent Director

    Sotac Pharmaceuticals IPO – Promoters Holding

    • Pre-Issue Share Holding – 84.63%
    • Post-Issue Share Holding – %

    Sotac Pharmaceuticals IPO Offer Details or Issue Details

     Particulars  No. Of Equity Shares
     Equity Shares Offered  Up to 3000000 Equity Shares aggregating up to Rs.3,330 Lakh
    of which:
    Issue Reserved for the Market Makers Up to 150000 Equity Shares aggregating up to Rs.[●]
    Net Issue to the Public Up to 2850000 Equity Shares aggregating up to Rs.[●]
    Of which:
    Retail Investors Portion Not less than 998400 Equity Shares
    Other than Retail Individual Investors Not more than 428400 Equity Shares
     Equity Shares outstanding prior to the Issue 8050000 Equity Shares
     Equity Shares outstanding after the Issue 11050000 Equity Shares

    Sotac Pharmaceuticals IPO Issue Object

    Their Company proposes to utilize the Net Proceeds towards funding the following objects:

    1. To Meet Working Capital Requirements
    2. Investment in Subsidiary
    3. Upgradation / Construction of Existing /New Building in the Existing Premises
    4. General Corporate Purpose
    5. To meet Public Issue Expenses

    Sotac Pharmaceuticals IPO – Business Strategy

    • Improve global presence
    • Leveraging their market skills and relationship
    • Maintaining an edge over competitors
    • Customer Satisfaction
    • Improve Product Portfolio

    Sotac Pharmaceuticals IPO – Basis of Offer Price

    The issue price is determined by the company in consultation with the Lead manager on the basis of the following qualitative and quantitative factors.

    Qualitative factors are:

    • Experienced Promoters and Management Team
    • Wide range of Products
    • Strategic Location of Manufacturing Facilities
    • Scalable Business Model
    • Quality assurance

    The relevant quantitative factors are:

    Basic & Diluted EPS RONW (%) NAV (Rs.)
    31-Mar-22 3.58 43.47% 8.23
    31-Mar-21 1.07 20.43%
    Mar-20 1.05 20.93%

    Sotac Pharmaceuticals IPO: Competitive Peers

    Face Value (Rs.) P/E EPS  (Rs.) Return on Net Worth (%) Total Income (Rs. in Lakhs)
    Sotac Pharmaceuticals Limited 10 [●] 3.58 43.47% 7,315.17
    Listed Peers
    Lincoln Pharmaceuticals Limited 10 9.14 34.63 16.02 47,207.89

    Sotac Pharmaceuticals IPO Lead Managers

    Lead Managers
    SEBI Registration Number: INM000012917
    Address: 807, Phoenix, Opp. Girish Cold Drinks, Near Vijay Cross Roads, Navrangpura,
    Ahmedabad -380009, Gujarat.
    Telephone Number: 079 4840 5357
    Email Id: mb@beelinemb.com
    Investors Grievance Id: ig@beelinemb.com
    Website: www.beelinemb.com
    Contact Person: Mr Nikhil Shah
    CIN: U67190GJ2020PTC114322

    Sotac Pharmaceuticals IPO Registrar to offer

    Registrar to the Offer
    SEBI Registration Number: INR000000221
    Address: Selenium Tower-B, Plot 31 & 32, Gachibowli, Financial District, Nanakramguda,
    Serilingampally, Hyderabad – 500 032, Telangana, India.
    Tel. Number: +91 40 6716 2222; Fax: +91 40 2343 1551
    Email Id: sotac.ipo@kfintech.com
    Investors Grievance Id: einward.ris@kfintech.com
    Website: www.kfintech.com
    Contact Person: Mr Murali Krishna
    CIN: U72400TG2017PLC117649

    Sotac Pharmaceuticals IPO – Other Details

    • Statutory Auditor – M/s. Keyur Shah & Co. Chartered Accountants
    • Legal Counsel to the Company – ANA ADVISORS
    • Bankers to the Company –  AXIS BANK LIMITED

    Sotac Pharmaceuticals IPO Review by Stock Brokers

    Top Stock Brokers Review Company Reputation Competitive Edge Financial Statement Popularity Index Promoters Reputation
    Angel Broking 7.5/10 7.4/10 8.5/10 8.1/10 7.1/10
    Sharekhan 7.2/10 7.1/10 8.6/10 8.1/10 7.2/10
    Kotak Securities 7.3/10 7.5/10 8.4/10 8.1/10 7.3/10
    ICICI Direct 7.3/10 7.3/10 8.7/10 8.1/10 7.1/10
    IIFL 7.5/10 7.2/10 8.8/10 8.0/10 7.1/10
    Edelweiss 7.5/10 7.4/10 8.4/10 8.3/10 7.2/10
    Zerodha 7.4/10 7.1/10 8.5/10 8.1/10 7.0/10
    5Paisa 7.1/10 7.1/10 8.4/10 8.1/10 7.1/10
    Karvy 7.4/10 7.3/10 8.2/10 8.1/10 7.1/10
    Motilal Oswal 7.1/10 7.1/10 8.6/10 8.3/10 7.2/10


    Subscribe to Sotac Pharmaceuticals IPO

      Fill Your Details Here
      1. Open Demat AccountInvest in IPO

      Sotac Pharmaceuticals Limited IPO News

      News 1 – IPO DRHP Download

      News 2 – IPO RHP Prospectus Download

      Sotac Pharmaceuticals IPO Review FAQs

      Check out various FAQs related to Sotac Pharmaceuticals IPO:

      What is the Issue Size of Sotac Pharmaceuticals IPO?

      The Company is making an initial public offer of 3,000,000 equity shares. They vividly portray the aspects of the issue in this article. You can check the stats on the fresh issue, Offer for sale, and net issue.

      What is the Price band of Sotac Pharmaceuticals IPO?

      The price band for this particular IPO ranges between Rs 105 to Rs 111. As far as the face value of the share is of concern, it is Rs. 10 per share.

      What is the Sotac Pharmaceuticals IPO Open Date?

      The opening and closing dates for this IPO have been updated. The IPO is set to open on Mar 29, 2023, while the closing date is set for Apr 3, 2023.

      What is the Sotac Pharmaceuticals IPO Allotment Date?

      They also have the news regarding the respective allotment dates of this IPO. The basis of Allotment finalization is on Apr 10, 2023, refund initiation is on Apr 11, 2023, credit of shares is on Apr 12, 2023, and share listing date is on Apr 13, 2023.

      What is the Sotac Pharmaceuticals IPO Listing Date?

      Shares of this company shall be listed in the exchanges on Apr 13, 2023. The date, when the listing would be done, is stagnant on Apr 13, 2023.

      Who is the Registrar of Sotac Pharmaceuticals IPO?

      One of the reputed registrars is managing the issue of this IPO, i.e. KFin Technologies Limited. Their website will help you regarding the further information you are on the lookout for.

      Who is the Promoter of Sotac Pharmaceuticals IPO?

      Here are the promoters of this IPO – MR. SHARADKUMAR DASHRATHBHAI PATEL, MR. DINESHKUMAR BABULAL GELOT, MR. VISHALKUMAR DEVRAJBHAI PATEL, MR. CHETANKUMAR BACHUBHAI PATEL AND MRS. KIRAN BALDEVBHAI JOTANIA. You can refer to the RHP for further information on the promoter. You will find the link to RHP in the article.

      What is the GMP of Sotac Pharmaceuticals IPO?

      They have obtained the GMP of this IPO and it is Rs NA. Further insights into the Kostak rate and subject to sauda or SS are as well included in this report.

      Is Sotac Pharmaceuticals IPO good for Investment?

      They have further provided the financial status of the company in this article, from the past few years. You can refer to the same, and also check the line of operations they are into and then decide to invest in the IPO.

      What is the PAT of Sotac Pharmaceuticals Company?

      They have the information on company financials, and according to that, they have the figures from the last few years to provide. PAT for the financial year 2022 in Lakh is 287.86, 2021 is (236.54), and 2020 is 8.75. PAT from Sep 2022 is 46.55.

      Calculate your return on investment!

      Asset Class ROI (Rs.) Profit (Rs.) Profit (%)
      Real Estate
      Fixed Deposit
      Mutual Fund

      Featured Topics


      Get 100% IPO Allotment Guarantee! Subscribe to IPO